Literature DB >> 30954957

Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis.

Ninna Hahn Tougaard1, Jens Faber1,2, Ebbe Eldrup1.   

Abstract

Diabetic euglycaemic ketoacidosis is a possible adverse effect of sodium-glucose co-transporter-2 inhibitors (SGLT2i). We report a case in which the combination of SGLT2i and a strict very low-carbohydrate diet led to severe diabetic ketoacidosis in a young Caucasian man with type 2 diabetes. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diabetes; diet; drugs: endocrine system; endocrine system; unwanted effects/adverse reaction

Mesh：

Substances：

Year:  2019        PMID： 30954957      PMCID： PMC6453281          DOI： 10.1136/bcr-2018-227516

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  10 in total

1.  Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors.

Authors:  Julio Rosenstock; Ele Ferrannini
Journal:  Diabetes Care       Date:  2015-09       Impact factor: 19.112

2.  Acute intractable vomiting and severe ketoacidosis secondary to the Dukan Diet©.

Authors:  Thomas F Freeman; Blake Willis; Diann M Krywko
Journal:  J Emerg Med       Date:  2014-08-22       Impact factor: 1.484

3.  Ketoacidosis during a low-carbohydrate diet.

Authors:  Pankaj Shah; William L Isley
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

4.  A life-threatening complication of Atkins diet.

Authors:  Tsuh-Yin Chen; William Smith; Jordan L Rosenstock; Klaus-Dieter Lessnau
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

Review 5.  The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes.

Authors:  Oren Steen; Ronald M Goldenberg
Journal:  Can J Diabetes       Date:  2017-10       Impact factor: 4.190

6.  Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.

Authors:  Juan P Frías; Cristian Guja; Elise Hardy; Azazuddin Ahmed; Fang Dong; Peter Öhman; Serge A Jabbour
Journal:  Lancet Diabetes Endocrinol       Date:  2016-09-16       Impact factor: 32.069

Review 7.  Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2.

Authors:  Sreeneeranj Kasichayanula; Xiaoni Liu; Frank Lacreta; Steven C Griffen; David W Boulton
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

8.  Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial.

Authors:  Bernhard Ludvik; Juan P Frías; Francisco J Tinahones; Julio Wainstein; Honghua Jiang; Kenneth E Robertson; Luis-Emilio García-Pérez; D Bradley Woodward; Zvonko Milicevic
Journal:  Lancet Diabetes Endocrinol       Date:  2018-02-23       Impact factor: 32.069

9.  Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study.

Authors:  Daisuke Yabe; Masahiro Iwasaki; Hitoshi Kuwata; Takuya Haraguchi; Yoshiyuki Hamamoto; Takeshi Kurose; Kiminobu Sumita; Hitoshi Yamazato; Shigeto Kanada; Yutaka Seino
Journal:  Diabetes Obes Metab       Date:  2017-02-21       Impact factor: 6.577

10.  Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet.

Authors:  Tomohide Hayami; Yoshiro Kato; Hideki Kamiya; Masaki Kondo; Ena Naito; Yukako Sugiura; Chika Kojima; Sami Sato; Yuichiro Yamada; Rina Kasagi; Toshihito Ando; Saeko Noda; Hiromi Nakai; Eriko Takada; Emi Asano; Mikio Motegi; Atsuko Watarai; Koichi Kato; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2015-02-20       Impact factor: 4.232
  10 in total
  6 in total

1.  Low-Carbohydrate and Very-Low-Carbohydrate Diets in Patients With Diabetes.

Authors:  Jennifer D Merrill; Diana Soliman; Nitya Kumar; Sooyoung Lim; Afreen I Shariff; William S Yancy
Journal:  Diabetes Spectr       Date:  2020-05

2.  Strawberry pink blood: hypertriglyceridaemia and diabetic ketoacidosis secondary to poorly controlled type 2 diabetes mellitus.

Authors:  Timothy Xin Zhong Tan; Steven Hoon Chin Lim; Joan Khoo
Journal:  BMJ Case Rep       Date:  2021-08-20

3.  An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists.

Authors:  Cyra-Yoonsun Kang; Parnia Khamooshi; Viviana Reyes Pinzon
Journal:  Cureus       Date:  2022-04-10

4.  Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report.

Authors:  Matthew Earle; Brian Ault; Caitlin Bonney
Journal:  Clin Pract Cases Emerg Med       Date:  2020-04-23

Review 5.  Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.

Authors:  Chaitong Churuangsuk; Julien Hall; Andrew Reynolds; Simon J Griffin; Emilie Combet; Michael E J Lean
Journal:  Diabetologia       Date:  2021-11-17       Impact factor: 10.122

Review 6.  Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver.

Authors:  Pimsiri Sripongpun; Chaitong Churuangsuk; Chalermrat Bunchorntavakul
Journal:  J Clin Transl Hepatol       Date:  2022-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.